Samsung’s AI lab in Montreal new Tiny Recursive Model with only 7M parameters performs as well, if not better in some instances, than systems much larger.
In this Q&A, Latent Labs CEO and AlphaFold co-developer Simon Kohl explains how generative A.I. is transforming biology from a science of prediction to one of design, why programmable drug ...
You're currently following this author! Want to unfollow? Unsubscribe via the link in your email. Follow Callie Ahlgrim Every time Callie publishes a story, you’ll get an alert straight to your inbox!